|
SYNCAN
Filed on: 1/3/2024
|
Pharmaceutical preparation for the treatment of epilepsy, Prader-Willi syndrome, obesity, graft versus host disease, gelastic seizures and seizures related to hypothalamic hamartoma, neonatal seizures, movement disorders including dystonia, central pain syndromes, phantom limb...
read more...
|
NEW APPLICATION FILED
1/3/2024
|
|
|
SYNCAN
Filed on: 1/15/2020
|
Pharmaceutical preparation for the treatment of epilepsy, Prader-Willi syndrome, obesity, graft versus host disease, gelastic seizures and seizures related to hypothalamic hamartoma, neonatal seizures, movement disorders including dystonia, central pain syndromes, phantom limb...
read more...
|
ABANDONED - NO STATEMENT OF USE FILED
2/5/2024
|
|
|
SYNCAN
Filed on: 6/24/2016
|
Pharmaceutical preparation for the treatment of epilepsy, Prader-Willi syndrome, obesity, graft versus host disease, gelastic seizures and seizures related to hypothalamic hamartoma, neonatal seizures, movement disorders including dystonia, central pain syndromes, phantom limb...
read more...
|
ABANDONED - NO STATEMENT OF USE FILED
2/17/2020
|
|